Company Profile

The Gerresheimer Group

Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Revenues by market segment

Underlying revenues at constant exchange rates financial year 2019 ≈ EUR 1.4bn

Gerresheimer - Revenues by market segment

Revenues by region

Gerresheimer - Revenues by economic area

Employees by region

Geresheimer - Employees by region

The Gerresheimer Group had about 10.000 employees as of the end of the financial year 2019.

Our Divisions

Our international business is split into three divisions, to which our individual Group companies are allocated:

Plastics & Devices

The product portfolio of the Plastics & Devices Division includes complex, customer-specific products for the simple and safe administration of medicines, such as insulin pens, inhalers and prefillable syringes. Also included are diagnostics and medical technology products such as lancets and test systems, as well as pharmaceutical plastic containers for liquid and solid medicines with closure and safety systems.

Primary Packaging Glass

The Primary Packaging Glass Division produces glass primary packaging for medicines and cosmetics, such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, plus special glass containers for the food and beverage industry.

Advanced Technologies

The Advanced Technologies Division develops and manufactures intelligent drug delivery systems. The Swiss tech company Sensile Medical forms the basis of this division, where we offer pharmaceutical and biotech companies drug delivery systems with state-of-the-art digital and electronic capabilities. Its portfolio currently comprises patented micro pumps, which are used to self-administer medication for Parkinson’s or heart failure, for example. Also in development is a platform for smart inhalation measurement systems.

Revenues by division

Underlying revenues at constant exchange rates financial year 2019 ≈ EUR 1.4bn

Gerresheimer - Revenues by division

You can find out more about our product range here.

Contact
Contact us!
Gerresheimer
Phone
+49 211 61 81-00
Mail